The long-term follow up of patients with oligoarticular juvenile idiopathic arthritis: a single center experience.
Medicinski Glasnik · 2025
DOI: 10.17392/1905-22-02 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicinski Glasnik, 2025. Verfasst von Aytan Aliyeva und 7 weiteren Autor:innen. Beteiligte Einrichtung: Istanbul University Cerrahpaşa, Istanbul, Turkey. Hauptthemen laut MEDLINE: Arthritis, Juvenile, Antirheumatic Agents.
Abstract (Originalsprache)
<div> <pre><strong><span lang="EN-US">Aim<br /></span></strong><span lang="EN-US">To evaluate the clinical course and outcomes of oligoarticular juvenile idiopathic arthritis(JIA) patients from 2003 to 2021, identifying factors linked to severe disease and complications.</span></pre> </div> <div> <pre><strong><span lang="EN-US">Methods</span></strong></pre> </div> <div> <pre><span lang="EN-US">We analyzed 208 oligoarticular JIA patients followed at Cerrahpaşa Medical School, using medical records. Continuous variables were compared with the Mann-Whitney U test, and logistic regression was applied to identify predictors of severe disease and damage.</span></pre> </div> <div> <pre><strong><span lang="EN-US">Results</span></strong></pre> </div> <div> <pre><span lang="EN-US">Among 208 patients (68.75% female), the average treatment duration was 45 months. The knee was the most affected joint (82.6%), followed by the ankle (50.4%). The initial mean Juvenil Arthritis Disease Activity Score (JADAS) score was 18, decreasing to 3 at the last visit. Juvenile Arthritis Damage Index (JADI) score averaged 0.64. Limited range of motion was observed in 34.13% patients. Uveitis was the most common extra-articular complication (14.9%), with higher biologic use in these patients (p<0.001). Disease severity correlated with initial and final JADAS (p<0.001) and JADI (p<0.001). Regression analysis linked elbow involvement (p=0.000) and adalimumab use (p=0.001) to disease sequelae. MEFV gene mutations were found in 10.9% of patients. Based on Wallace criteria, 85% were in remission with medication, 6.25% had inactive disease, and 8.6% achieved drug-free remission.</span></pre> </div> <div> <pre><strong><span lang="EN-US">Conclusion: </span></strong><span lang="EN-US">Oligoarticular JIA generally has a mild course and good prognosis. However, elbow involvement and biologic use are associated with more severe disease and sequelae. Uveitis is the most common extra-articular complication.</span></pre> </div> <div> <pre><strong><span lang="EN-US">Keywords: </span></strong><span lang="EN-US">arthritis, biologics, damage, oligoarticular JIA</span></pre> </div>
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Istanbul University Cerrahpaşa, Istanbul, Turkey.
Zitieren
APA
Aliyeva, A., Adrovic, A., Aslak, F., Koker, O., Yildiz, M., Sahin, S., Barut, K., & Kasapcopur, O. (2025). The long-term follow up of patients with oligoarticular juvenile idiopathic arthritis: a single center experience. Medicinski Glasnik. https://doi.org/10.17392/1905-22-02
Vancouver
Aliyeva A, Adrovic A, Aslak F, Koker O, Yildiz M, Sahin S, et al. The long-term follow up of patients with oligoarticular juvenile idiopathic arthritis: a single center experience. Medicinski Glasnik. 2025. doi:10.17392/1905-22-02
BibTeX
@article{Aliyeva2025,
author = {Aliyeva, Aytan and Adrovic, Amra and Aslak, Fatih and Koker, Oya and Yildiz, Mehmet and Sahin, Sezgin and Barut, Kenan and Kasapcopur, Ozgur},
title = {The long-term follow up of patients with oligoarticular juvenile idiopathic arthritis: a single center experience},
journal = {Medicinski Glasnik},
year = {2025},
doi = {10.17392/1905-22-02}
}
EUVIMED